KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Imax (IMAX) Operating Income (2016 - 2026)

Imax's Operating Income history spans 17 years, with the latest figure at $10.0 million for Q1 2026.

  • On a quarterly basis, Operating Income fell 40.53% to $10.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $77.4 million, a 59.59% increase, with the full-year FY2025 number at $84.2 million, up 92.03% from a year prior.
  • Operating Income hit $10.0 million in Q1 2026 for Imax, down from $24.1 million in the prior quarter.
  • Over the last five years, Operating Income for IMAX hit a ceiling of $29.0 million in Q3 2025 and a floor of -$4.2 million in Q3 2022.
  • Historically, Operating Income has averaged $10.6 million across 5 years, with a median of $11.4 million in 2023.
  • Biggest five-year swings in Operating Income: plummeted 396.83% in 2022 and later soared 14185.15% in 2023.
  • Tracing IMAX's Operating Income over 5 years: stood at -$629000.0 in 2022, then skyrocketed by 535.45% to $2.7 million in 2023, then surged by 247.28% to $9.5 million in 2024, then surged by 153.41% to $24.1 million in 2025, then plummeted by 58.72% to $10.0 million in 2026.
  • Business Quant data shows Operating Income for IMAX at $10.0 million in Q1 2026, $24.1 million in Q4 2025, and $29.0 million in Q3 2025.